Kolexia
Schmidt Nicolas
Neurologie
Sas Centre Onakia Mayotte
Mamoudzou, France
30 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie d'Alzheimer Démence Sclérose en plaques Naissance prématurée Trichothiodystrophies COVID-19 Sclérose Mortinatalité {{person.topmesh10.name}}

Industries

Merck-Serono
21 collaboration(s)
Dernière en 2023
Sanofi
20 collaboration(s)
Dernière en 2023
B3TSI
5 collaboration(s)
Dernière en 2023
Biogen
3 collaboration(s)
Dernière en 2023

Dernières activités

Pregnant women with mild COVID-19 followed in community setting by telemedicine, and factors associated with unfavorable outcome.
PloS one   03 août 2023
A functional link between lariat debranching enzyme and the intron-binding complex is defective in non-photosensitive trichothiodystrophy.
Molecular cell   26 juin 2023
Activity of Masitinib (AB1010) in Mild to Moderate Alzheimer's Disease: A Multicenter, Double-blind, Placebo-controlled, Randomized, Parallel-group Study to Evaluate the Efficacy of Oral AB1010 in Adults Patients With Mild to Moderate Alzheimer-type Disease.
Essai Clinique (AB Science)   12 décembre 2018
Cross-Sectional and longitudinal associations of objectively-measured physical activity on blood pressure: evaluation in 37 countries.
Health promotion perspectives   26 septembre 2017
Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study.
BMC neurology   12 juin 2012
Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial.
Alzheimer's research & therapy   19 avril 2011
{{person.lastact7.name}}
{{person.lastact7.jour}}   {{person.lastact7.date}}
{{person.lastact8.name}}
{{person.lastact8.jour}}   {{person.lastact8.date}}
{{person.lastact9.name}}
{{person.lastact9.jour}}   {{person.lastact9.date}}
{{person.lastact10.name}}
{{person.lastact10.jour}}   {{person.lastact10.date}}